Theratechnologies Inc.
NASDAQ:THTX
Overview | Financials
Company Name | Theratechnologies Inc. |
Symbol | THTX |
Currency | USD |
Price | 1.8 |
Market Cap | 82,764,034 |
Dividend Yield | 0% |
52-week-range | 1.08 - 2.18 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Paul Lévesque |
Website | https://www.theratech.com |
An error occurred while fetching data.
About Theratechnologies Inc.
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD